Research/Areas of Interest:
Drug development strategy, policy, and economics.
Education
- MD, Columbia University Medical Center, New York, United States, 2001
- PhD, Columbia University Medical Center, New York, United States, 2001
Biography
Frank S. David, MD, PhD, is Professor of the Practice of Biotechnology in the Department of Biology at Tufts University. He is also Managing Director of the biotech R&D strategy consulting firm Pharmagellan and a member of the Harvard-MIT Center for Regulatory Science.
Dr. David's work aims to help established and emerging biomedical companies, entrepreneurs, and investors maximize the value of innovative R&D. An active consultant, author, and educator, his current interests include approaches to assessing and managing R&D risk for new therapies; the analysis and interpretation of clinical trial results; regulatory strategy and policy for novel drugs; drug pricing and the economics of the biopharma industry; and financial modeling of R&D-stage therapeutics.
At Tufts, Dr. David coordinates a biopharma internship program for biology MS students, teaches courses on drug development, and leads seminars on professional skills and career development.
Dr. David's work aims to help established and emerging biomedical companies, entrepreneurs, and investors maximize the value of innovative R&D. An active consultant, author, and educator, his current interests include approaches to assessing and managing R&D risk for new therapies; the analysis and interpretation of clinical trial results; regulatory strategy and policy for novel drugs; drug pricing and the economics of the biopharma industry; and financial modeling of R&D-stage therapeutics.
At Tufts, Dr. David coordinates a biopharma internship program for biology MS students, teaches courses on drug development, and leads seminars on professional skills and career development.